𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lymphatic micrometastases in patients with early esophageal adenocarcinoma

✍ Scribed by Brechtje A. Grotenhuis; Mark van Heijl; Bas P. L. Wijnhoven; Mark I. van Berge Henegouwen; Katharina Biermann; Fiebo J. W. ten Kate; Olivier R. C. Busch; Winand N. M. Dinjens; Hugo W. Tilanus; J. Jan B. van Lanschot

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
191 KB
Volume
102
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

p53 correlates with improved survival in
p53 correlates with improved survival in patients with esophageal adenocarcinoma
✍ Edward R. Sauter; Steven M. Keller; Susan M. Erner πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 412 KB

Esophageal adenocarcinoma is a virulent malignancy that is rapidly increasing in incidence. Overexpression of p53, a tumor-suppressor gene with prognostic significance in many malignancies, has not been adequately evaluated in this disease. The purpose of this study was to evaluate the pattern and i

Bone marrow micrometastases in a patient
Bone marrow micrometastases in a patient with localized Wilms' tumor
✍ Dominici, Carlo; Gregory, Silvia; Padula, Anthony; Fares, Cristina; Ceccamea, Al πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 460 KB πŸ‘ 2 views

The case of a 7-year-old boy presenting at diagnosis with a localized (stage 111) Wilms' tumor of favorable histology is presented. lmmunocytologic analysis of bone marrow aspirates revealed cells positive for neural cell adhesion molecule (NCAM) and negative for class I major histocompatibility com

The addition of induction chemotherapy t
The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma
✍ S. Chris Malaisrie; Wayne L. Hofstetter; Arlene M. Correa; Jaffer A. Ajani; Rits πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 193 KB

## Abstract ## BACKGROUND. Tumor viability assessed by pathologic analysis of resected specimens in patients with preoperatively treated esophageal adenocarcinoma (EAC) is a prognostic indicator. The feasibility of induction chemotherapy followed by concurrent chemoradiotherapy (CCRT) and surgery